Gina Mauro

Five-fraction SBRT was noninferior to radiotherapy in a phase 3 trial of patients with low- to intermediate-risk localized prostate cancer.

Microscopic image of CAR T cells - Generated with Google Gemini AI

Barriers and gaps in treatment and care for patients diagnosed with gynecologic cancers were reported in a recent survey.

The FDA has approved revumenib (Revuforj) for the treatment of patients with relapsed/refractory acute leukemia with a KMT2A translocation in adult and pediatric patients 1 year and older.

Enfortumab vedotin with pembrolizumab and nivolumab with cisplatin and gemcitabine are FDA-approved, improving survival in urothelial carcinoma.

The incorporation of palliative care specific to mental health services and therapy remains underutilized in the care of patients with pancreatic cancer.

PD-L1 expression predicts better outcomes with nivolumab and ipilimumab in ccRCC, aligning with previous trial results.

Approximately one-third of patients with pancreatic cancer and anxiety had a palliative care consultation, data showed.

Magrolimab plus docetaxel improved outcomes in metastatic NSCLC patients with high CD47 expression, showing a median PFS of 8.9 months versus 2.6 months for lower expression.

IGV-001 showed no new risks compared to placebo in a phase 2b trial for glioblastoma, with 86 serious adverse effects reported.